Biofil Chemicals Intrinsic Value
Biofil Chemicals (BIOFILCHEM) median intrinsic value is ₹26.25 from 9 valuation models (range ₹13–₹38), vs current price ₹32.39 — -19.0% downside (Trading Above Median Value), margin of safety -23.4%. Analyse Biofil Chemicals shareholding analysis to track promoter, FII and institutional holdings.
BIOFILCHEM Valuation Methods Summary — DCF, Graham Number & P/E
Biofil Chemicals intrinsic value across 9 models vs current price ₹32.39 — upside/downside and value range per method. Read BIOFILCHEM ex-dividend dates for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹37.62 | ₹30.10 - ₹45.14 | +16.1% | EPS: ₹1.71, Sector P/E: 22x |
| Book Value Method | asset | ₹23.75 | ₹21.38 - ₹26.13 | -26.7% | Book Value/Share: ₹11.88, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹35.00 | ₹31.50 - ₹38.50 | +8.1% | Revenue/Share: ₹17.50, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹12.96 | ₹11.66 - ₹14.26 | -60.0% | EBITDA: ₹1.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹16.98 | ₹13.58 - ₹20.38 | -47.6% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹27.36 | ₹24.62 - ₹30.10 | -15.5% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹26.30 | ₹23.67 - ₹28.93 | -18.8% | Revenue Growth: 5.0%, Adj P/E: 15.4x |
| ROE Based Valuation | profitability | ₹26.25 | ₹23.62 - ₹28.88 | -19.0% | ROE: 15.8%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹21.38 | ₹19.24 - ₹23.52 | -34.0% | EPS: ₹1.71, BVPS: ₹11.88 |
BIOFILCHEM Intrinsic Value vs Market Price — All Valuation Models
Biofil Chemicals fair value range ₹13–₹38 vs current market price ₹32.39 across 9 valuation models. For current market price and key ratios, visit Biofil Chemicals stock price NSE.
BIOFILCHEM Intrinsic Value Analysis — Undervalued or Overvalued?
Biofil Chemicals median intrinsic value ₹26.25, current price ₹32.39 — Trading Above Median Value by 19.0%, margin of safety -23.4%.
What is the intrinsic value of BIOFILCHEM?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Biofil Chemicals (BIOFILCHEM) is ₹26.25 (median value). With the current market price of ₹32.39, this represents a -19.0% variance from our estimated fair value.
The valuation range spans from ₹12.96 to ₹37.62, indicating ₹12.96 - ₹37.62.
Is BIOFILCHEM undervalued or overvalued?
Based on our multi-method analysis, Biofil Chemicals (BIOFILCHEM) appears to be trading above median value by approximately 19.0%.
BIOFILCHEM Financial Health — Key Ratios vs Industry Benchmarks
Biofil Chemicals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 15.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.55x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
BIOFILCHEM Cash Flow Quality — Operating & Free Cash Flow
Biofil Chemicals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |